Evolugate Improves DNA-Plasmid Production, Ready to Impact Covid-19 Vaccines Manufacturing Throughput

Evolugate, LLC, a Gainesville-based biotech company, has demonstrated that its proprietary technology can be used to improve the throughput of plasmid DNA manufacturing. Plasmids are essential for nucleic acid-based vaccines and gene therapies. Efficient plasmid production represents a significant bottleneck in the large scale manufacture of several Covid-19 vaccines. Plasmids are mass produced in bacteriaContinue reading “Evolugate Improves DNA-Plasmid Production, Ready to Impact Covid-19 Vaccines Manufacturing Throughput”